We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Alarm.com
ALRM
$2.71B
| $20.4M | 0.08% |
373,600
+5,000
| +1% | +$307K |
|
227
Idexx Laboratories
IDXX
$43.9B
| $20.4M | 0.08% |
40,410
+75
| +0.2% | +$36.4K |
|
228
Royalty Pharma
RPRX
$26.2B
| $20.4M | 0.08% |
721,327
+6,298
| +0.9% | +$174K |
|
229
EXL Service
EXLS
$5.2B
| $20.2M | 0.08% |
530,290
+490,000
| +1,216% | +$17.1M |
|
230
Alnylam Pharmaceuticals
ALNY
$30.3B
| $20.1M | 0.08% |
73,181
+130
| +0.2% | +$33.8K |
|
|
BNY
231
Bank of New York Mellon
BNY
$110B
| $20.1M | 0.08% |
279,329
+20,772
| +8% | +$1.37M |
|
232
ResMed
RMD
$32.6B
| $19.9M | 0.08% |
81,554
+3,171
| +4% | +$709K |
|
233
VICI Properties
VICI
$28.9B
| $19.8M | 0.08% |
593,852
+47,953
| +9% | +$1.52M |
|
234
Agilent Technologies
A
$41.9B
| $19.7M | 0.08% |
132,579
-367
| -0.3% | -$50.2K |
|
235
CBIZ
CBZ
$2.96B
| $19.6M | 0.08% |
292,000
+280,000
| +2,333% | +$20.3M |
|
236
Corning
GLW
$143B
| $19.6M | 0.08% |
434,609
+3,325
| +0.8% | +$140K |
|
237
Kimberly-Clark
KMB
$36.5B
| $19.5M | 0.08% |
136,986
-547
| -0.4% | -$77.6K |
|
238
Roper Technologies
ROP
$38.5B
| $19.3M | 0.08% |
34,756
-865
| -2% | -$476K |
|
239
Baidu
BIDU
$35.4B
| $19.2M | 0.08% |
182,817
+15,000
| +9% | +$1.32M |
|
240
Sea Limited
SE
$75.5B
| $19.2M | 0.08% |
203,370
+32,487
| +19% | +$2.45M |
|
241
Hilton Worldwide
HLT
$72.4B
| $19.1M | 0.08% |
82,901
+8,549
| +11% | +$1.85M |
|
242
Microchip Technology
MCHP
$43.2B
| $19M | 0.08% |
236,950
+12,558
| +6% | +$1.04M |
|
243
Merit Medical Systems
MMSI
$5.42B
| $19M | 0.08% |
192,109
+178,800
| +1,343% | +$16.4M |
|
244
AvalonBay Communities
AVB
$26.2B
| $18.9M | 0.07% |
84,068
+2,074
| +3% | +$448K |
|
245
Aon
AON
$74.7B
| $18.8M | 0.07% |
54,478
+396
| +0.7% | +$130K |
|
246
lululemon athletica
LULU
$13.6B
| $18.7M | 0.07% |
68,951
+775
| +1% | +$206K |
|
247
Apollo Global Management
APO
$83.3B
| $18.5M | 0.07% |
148,067
-1,269
| -0.8% | -$146K |
|
248
Workday
WDAY
$43.6B
| $18.4M | 0.07% |
75,301
+1,611
| +2% | +$380K |
|
249
Trade Desk
TTD
$6.52B
| $18.2M | 0.07% |
166,358
+1,883
| +1% | +$188K |
|
250
US Bancorp
USB
$102B
| $18.2M | 0.07% |
397,884
+3,761
| +1% | +$165K |
|
Similar funds
VIA
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.